Curcumin vs Sulforaphane
Two plant-derived anti-inflammatory compounds with a shared problem — real cell-biology mechanisms undermined by how badly the body actually absorbs them.
Short answer
Neither curcumin nor sulforaphane needs a prescription, and both have human data, so the goal decides it. Curcumin is marketed for anti-inflammatory use and joint pain; sulforaphane is the choice for readers interested in Nrf2 activation, antioxidant defense and anti-aging.
Curcumin
Turmeric extract
Decent RCT/meta-analysis support for osteoarthritis pain — but curcumin is barely absorbed (hence piperine/formulations) and a textbook PAINS compound that lights up assays deceptively.
Full Curcumin evidence reviewSulforaphane
Broccoli-sprout extract
Genuine human RCTs — but in autism and type-2 diabetes, not aging; the longevity claims rest on the Nrf2 pathway in cells and animals.
Full Sulforaphane evidence reviewCurcumin vs Sulforaphane: head to head
- FDA status / approved use
Curcumin
Sold as a supplementSulforaphane
Sold as a supplement; many products contain a precursor rather than active sulforaphane- Marketed for
Curcumin
Anti-inflammatory, joint painSulforaphane
Nrf2 / antioxidant defense, anti-aging- Outcome areas
Curcumin
Joint / bone health; Immune function / inflammationSulforaphane
Blood sugar / insulin sensitivity; Longevity / lifespan- Evidence grade
Curcumin
Clinical dataSulforaphane
Clinical data- How it works
Curcumin
Turmeric polyphenol; many lab-reported mechanisms are likely assay artifactsSulforaphane
Activates Nrf2, switching on the cell's antioxidant and detox genes- Route and dosing
Curcumin
Oral, often in formulations engineered for better absorptionSulforaphane
Oral, from broccoli sprouts or supplements- Headline human result
Curcumin
Pain 2.04 points lower on a visual analog scale vs placebo in a meta-analysis of eight osteoarthritis RCTsSulforaphane
About 34% improvement on the ABC behavior scale vs placebo over 18 weeks in a 2014 autism RCT; no aging trials- Strongest evidence
Curcumin
Joint-pain meta-analysis, J Med Food 2016Curcumin evidence reviewPubMed 27533649Sulforaphane
T2D RCT, Sci Transl Med 2017Sulforaphane evidence reviewPubMed 28615356- Key safety signal
Curcumin
Usually mild GI effects; added piperine inhibits drug-metabolizing enzymes, raising interaction riskSulforaphane
Low toxicity; concentrated supplements can cause mild GI upset- How it is obtained
Curcumin
Over the counter as a dietary supplementSulforaphane
Over the counter as a dietary supplement
| Curcumin | Sulforaphane | |
|---|---|---|
| FDA status / approved use | Sold as a supplement | Sold as a supplement; many products contain a precursor rather than active sulforaphane |
| Marketed for | Anti-inflammatory, joint pain | Nrf2 / antioxidant defense, anti-aging |
| Outcome areas | Joint / bone health; Immune function / inflammation | Blood sugar / insulin sensitivity; Longevity / lifespan |
| Evidence grade | Clinical data | Clinical data |
| How it works | Turmeric polyphenol; many lab-reported mechanisms are likely assay artifacts | Activates Nrf2, switching on the cell's antioxidant and detox genes |
| Route and dosing | Oral, often in formulations engineered for better absorption | Oral, from broccoli sprouts or supplements |
| Headline human result | Pain 2.04 points lower on a visual analog scale vs placebo in a meta-analysis of eight osteoarthritis RCTs | About 34% improvement on the ABC behavior scale vs placebo over 18 weeks in a 2014 autism RCT; no aging trials |
| Strongest evidence | Joint-pain meta-analysis, J Med Food 2016Curcumin evidence reviewPubMed 27533649 | T2D RCT, Sci Transl Med 2017Sulforaphane evidence reviewPubMed 28615356 |
| Key safety signal | Usually mild GI effects; added piperine inhibits drug-metabolizing enzymes, raising interaction risk | Low toxicity; concentrated supplements can cause mild GI upset |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
Our verdict
Curcumin has decent RCT support for joint and arthritis pain, but it's barely absorbed on its own and is a well-known 'PAINS' compound — one that interferes with lab assays in ways that have generated a lot of false-positive research interest. Sulforaphane's Nrf2-activation mechanism is real and well-characterized, with some genuinely positive human trials in specific niches, but 'anti-aging' broadly isn't one of the niches with real data. Both need a real delivery-form check (piperine-enhanced curcumin, myrosinase-active broccoli-sprout extract) before the underlying mechanism has a fair shot at working.
Curcumin fits if
Joint or arthritis-related pain is the specific target, with a bioavailability-enhanced formulation.
Sulforaphane fits if
The Nrf2/detoxification-enzyme mechanism is the interest, understanding the niches with real human data are narrower than general 'anti-aging' marketing implies.
Curcumin vs Sulforaphane: common questions
- Is either curcumin or sulforaphane FDA-approved?
- No. Curcumin is sold as a supplement. Sulforaphane is sold as a supplement; many products contain a precursor rather than active sulforaphane.
- Which has stronger human evidence, curcumin or sulforaphane?
- Neither clearly. Both have human clinical data. The key source for curcumin is Joint-pain meta-analysis, J Med Food 2016; for sulforaphane, it is T2D RCT, Sci Transl Med 2017.
- What are the main safety concerns with curcumin and sulforaphane?
- For curcumin, watch for usually mild GI effects; added piperine inhibits drug-metabolizing enzymes, raising interaction risk. Sulforaphane has low toxicity; concentrated supplements can cause mild GI upset.
Key studies behind each
Curcumin
- Daily JW, Yang M, Park S. (2016). Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. PubMed 27533649
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm. PubMed 17999464
- Shoba G, Joy D, Joseph T, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. PubMed 9619120
- Nelson KM, Dahlin JL, Bisson J, et al. (2017). The Essential Medicinal Chemistry of Curcumin. J Med Chem. PubMed 28074653
Sulforaphane
- Axelsson AS, Tubbs E, Mecham B, et al. (2017). Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med. PubMed 28615356
- Singh K, Connors SL, Macklin EA, et al. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. PubMed 25313065
- Fahey JW, Wade KL, Wehage SL, et al. (2017). Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency. Mol Nutr Food Res. PubMed 27935214
- Fahey JW, Holtzclaw WD, Wehage SL, et al. (2015). Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase. PLoS One. PubMed 26524341
The full evidence reviews
- Curcumin: decent for joint pain, deceptive in a test tube
Turmeric's polyphenol has respectable randomized data for arthritis pain and modest mood/metabolic signals — but it is barely absorbed, and chemists formally flag it as a compound that fools lab assays.
Updated August 2026
- Sulforaphane: real human data, in niches that aren't longevity
The broccoli-sprout Nrf2 activator has genuine randomized trials — for autism and type-2 diabetes. But its anti-aging claims are preclinical, and bioavailability depends heavily on the preparation.
Updated August 2026